Assort Health, the San Francisco startup that began by teaching a voice AI to book a single specialty appointment, has closed a $120 million Series C led by Menlo Ventures, valuing the company at $1.2 billion and cementing its claim to one of the largest deployments of AI agents anywhere in healthcare administration.
The round, announced June 24, brings Assort's total capital raised to more than $222 million. Alongside new lead Menlo Ventures, the financing drew participation from Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Tau Ventures, Quiet Capital, and former NFL quarterback Joe Montana. Menlo partner JP Sanday is joining Assort's board of directors.
The capital arrives on the back of explosive commercial traction. Assort says revenue has grown 20x over the past 15 months as it pushes out of large physician groups and into enterprise health systems and academic medical centers. The platform now spans dermatology, cardiology, OB-GYN, dentistry, and more than a dozen other specialties, having accumulated north of 190 million patient voice interactions.
From Voice Bot to System of Record
Founded by co-CEOs Jon Wang, a Stanford machine-learning researcher who has published seven papers on AI and healthcare, and Jeffery Liu, a former head of product engineering at a $7 billion healthcare company, Assort started in orthopedics, where front-office complexity is among the highest in outpatient medicine. Before writing code, the pair spent months on-site shadowing schedulers and interviewing more than 200 outpatient groups.
What began as voice AI for scheduling has grown into a connected suite of agents organized around four modules. Concierge handles inbound calls, clinical triage, lab coordination, and multilingual scheduling. Activate reaches out proactively to close referral loops, recover no-shows, and resolve outstanding balances. Orchestrate runs the back-office work of each visit and writes every detail back to the EHR. Empower gives front-desk staff an AI copilot. Tying it together is what Assort calls Patient Journey Memory, a persistent record that lets the system recognize a patient's insurance history, prior alerts, and medication preferences the instant they reconnect, rather than treating every call as an isolated event.
Under the hood is Synapse, Assort's proprietary specialty model trained on 190 million patient interactions, 62,000 care protocols, and 1.6 million decision pathways. The company argues that generic large language models break down in high-acuity scheduling, where routing a single specialty appointment can require navigating thousands of doctor-specific rules and lab prerequisites. Synapse, it says, maps edge cases and runs internal simulations to stay reliable inside nuanced provider settings.
Why Investors Are Betting on the Front Office
Menlo's thesis is blunt: the administrative front door of healthcare is broken, and AI is the first credible fix. In its investment note, the firm described "the binder" found in nearly every outpatient practice, a worn folder of Post-it notes encoding scheduling rules that live only in the heads of a few tenured staff. "For decades, the binder has controlled the front door of healthcare," Menlo wrote, noting that administrative overhead consumes nearly an eighth of all U.S. healthcare spending.
"Every so often a company comes along that fundamentally reimagines how an industry operates. Assort is that company for healthcare," said JP Sanday, partner at Menlo Ventures. "They've built not just another point solution, but a unified platform of AI agents that elevates the entire patient journey."
The appeal is structural. Menlo's own State of AI in Healthcare research flagged patient engagement and the front office as the single biggest area of projected new AI spend among health system operators. When schedulers quit, the institutional knowledge in the binder walks out with them; Assort's pitch is that the platform absorbs that knowledge permanently and keeps getting smarter with every interaction.
Early results give the bet some teeth. California-based John Muir Health is deploying Assort's agents directly over its Epic and Athena systems, which the company says unlocked a 115% increase in administrative labor capacity and a 5% absolute lift in net appointment volume without disrupting clinical workflows. Customers including Jon Shaker of the Boston Bone and Joint Institute and Dr. Parinita Amin of MDCS Dermatology report automation rates climbing quarter over quarter.
What to Watch
Assort is wading into one of the most crowded corners of health-tech, where voice AI vendors are racing to automate call centers and scheduling. Its differentiation rests on two claims that the next year will test: that specialty-specific training meaningfully beats general-purpose models on safety and resolution, and that Patient Journey Memory creates a durable data moat as rivals close the gap.
The harder proof point is enterprise scale. Moving from multi-site physician groups into academic medical centers and large regional networks means deeper Epic integrations, stricter compliance, and longer sales cycles. With 20x growth and a fresh $120 million in the bank, Assort has the runway to chase that market. Whether it can keep its automation rates high as the patient journeys it manages grow more complex will determine if this front door stays open.
"Every so often a company comes along that fundamentally reimagines how an industry operates. Assort is that company for healthcare. They've built not just another point solution, but a unified platform of AI agents that elevates the entire patient journey."- JP Sanday, Partner, Menlo Ventures